Conditions: Gastric Ulcer Duodenal Ulcer Rheumatoid Arthritis Osteoarthritis Lumbago
Keywords: gastrointestinal GI NSAID Japan Japanese Gastric ulcer duodenal ulcer
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 395
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the Safety and tolerability of D961H (Esomeprazole) 20 mg once daily for up to 52 weeks of treatment involving patients with a history of gastric and/or duodenal ulcers receiving daily nonsteroidal anti-inflammatory drug (NSAID) therapy by evaluating AE, clinical laboratory value and vital signs.

Detailed description:

Arms:
arm 1: Esomeprazole 20 mg once daily

Interventions: intervention 1: Esomeprazole 20 mg
Intervention descriptions: intervention 1: Esomeprazole 20 mg once daily

Protocol document: